[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 41, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 55, "title": "Chief Scientific Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 40, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 51, "title": "Chief People Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.285, "open": 1.29, "dayLow": 1.29, "dayHigh": 1.5279, "regularMarketPreviousClose": 1.285, "regularMarketOpen": 1.29, "regularMarketDayLow": 1.29, "regularMarketDayHigh": 1.5279, "payoutRatio": 0.0, "beta": -0.228, "forwardPE": -0.87804884, "volume": 631320, "regularMarketVolume": 631320, "averageVolume": 190648, "averageVolume10days": 232110, "averageDailyVolume10Day": 232110, "bid": 1.42, "ask": 1.49, "bidSize": 2, "askSize": 1, "marketCap": 51819412, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 3.83, "fiftyDayAverage": 1.4229, "twoHundredDayAverage": 1.765375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20036434, "profitMargins": 0.0, "floatShares": 27332940, "sharesOutstanding": 35985700, "sharesShort": 866083, "sharesShortPriorMonth": 1067482, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0241, "heldPercentInsiders": 0.23999001, "heldPercentInstitutions": 0.12579, "shortRatio": 5.63, "shortPercentOfFloat": 0.0315, "impliedSharesOutstanding": 35985700, "bookValue": 1.163, "priceToBook": 1.2381772, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -61774912, "trailingEps": -1.97, "forwardEps": -1.64, "enterpriseToEbitda": -0.314, "52WeekChange": -0.12585032, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 1.44, "targetHighPrice": 21.0, "targetLowPrice": 1.5, "targetMeanPrice": 10.75, "targetMedianPrice": 10.5, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 35865696, "totalCashPerShare": 0.997, "ebitda": -63850176, "totalDebt": 4082719, "quickRatio": 7.021, "currentRatio": 7.479, "debtToEquity": 9.757, "returnOnAssets": -0.57901, "returnOnEquity": -1.02475, "freeCashflow": -32395848, "operatingCashflow": -53589096, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 2.08333, "postMarketPrice": 1.47, "postMarketChange": 0.03, "regularMarketChange": 0.15500009, "regularMarketDayRange": "1.29 - 1.5279", "regularMarketPrice": 1.44, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 12.062264, "corporateActions": [], "postMarketTime": 1747433955, "regularMarketTime": 1747425601, "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 190648, "fiftyTwoWeekLowChange": 0.44000006, "fiftyTwoWeekLowChangePercent": 0.44000006, "fiftyTwoWeekRange": "1.0 - 3.83", "fiftyTwoWeekHighChange": -2.3899999, "fiftyTwoWeekHighChangePercent": -0.6240209, "fiftyTwoWeekChangePercent": -12.5850315, "epsTrailingTwelveMonths": -1.97, "epsForward": -1.64, "epsCurrentYear": -1.6025, "priceEpsCurrentYear": -0.898596, "fiftyDayAverageChange": 0.017100096, "fiftyDayAverageChangePercent": 0.012017778, "twoHundredDayAverageChange": -0.32537496, "twoHundredDayAverageChangePercent": -0.18430926, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.7 - Buy", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]